NASDAQ NMS - GLOBAL MARKET · BNTC
-5.71% · -$0.7700 · Vol 122.5K
Market closed · last close 4:00 PM ET · price as of 16:00:36 ET
Benitec Biopharma Inc

Benitec Biopharma Inc

Biotechnology
$12.71
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
BNTC
Benitec Biopharma Inc
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

68/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BNTC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BNTC catalysts
About Benitec Biopharma Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2012
Employees
19
Country
US

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$13.53
Day high
$13.64
Day low
$12.47
Previous close
$13.48
52W high
$16.52
-23.06% from high
52W low
$10.06
41% of range
Market cap
$463.1M
EPS
$-0.9600
Beta
1.21
Shares out
34.4M
Volume
122.5K
0.84× rel vol
Avg volume
145.5K
VWAP
$13.01
Price history computed in-house
1W
-1.32%
1M
+10.81%
3M
+9.57%
1Y
-3.79%
YTD
-5.64%
SMA 50 $12.60 · above
SMA 200 $12.13 · above
52W position 41%

BNTC overview

Veridion Score
68
Registered · 2026-08-24
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BNTC.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BNTC Form 4 filings
Public disclosures

Congress activity in BNTC

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BNTC in the cached public ledger.

Federal contracts

BNTC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BNTC in this window.
Lobbying spend

BNTC lobbying filings, year to date.

Registered lobbying filings matched to Benitec Biopharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BNTC in this window.
Loading news for BNTC
Analyst ratings
Sovereign unlock shows live analyst consensus for BNTC.
Options
Sovereign unlock shows live options positioning for BNTC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.